The Valley Desk

NCT02239120 · Interventional trial

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Overall registry status Completed

Phase 3

Conditions Secondary Prevention, Stroke

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov